Speaker(s): 

Varun Pulakanti, MD, Physician, Geisinger - has nothing to disclose.

Learning Objectives: 

1. Discuss results of trials presented regarding endovascular therapy for medium vessel occlusions.
2. Discuss outcomes regarding efforts to expand usage of IV thrombolytics.
3. Review any updates to AHA Stroke Guidelines.
4. Review our current practice in working up and treating primary CNS vasculitides.

At the conclusion of this session, the participant should be able to: 

 Follow up Questions: 

1. How do the results of the MeVO thrombectomy trials change our clinical practice?
2. How can we work with Radiology to expand use clinically useful imaging tools such as intraluminal studies and rapid MRIs?
3. Which patients do we think may benefit most from IA thrombolytics?

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Anthony Noto, MD, David Ermak, DO, Lisa Wasko, BSN, RN, SCRN have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None